198 related articles for article (PubMed ID: 30008876)
1. Dermatofibrosarcoma protuberans: A clinical analysis.
Lyu A; Wang Q
Oncol Lett; 2018 Aug; 16(2):1855-1862. PubMed ID: 30008876
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for distant metastasis of dermatofibrosarcoma protuberans.
Hayakawa K; Matsumoto S; Ae K; Tanizawa T; Gokita T; Funauchi Y; Motoi N
J Orthop Traumatol; 2016 Sep; 17(3):261-6. PubMed ID: 27289468
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
[TBL] [Abstract][Full Text] [Related]
4. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
[TBL] [Abstract][Full Text] [Related]
5. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features, Pathological Findings and Treatment of Recurrent Dermatofibrosarcoma Protuberans.
Li Y; Wang C; Xiang B; Chen S; Li L; Ji Y
J Cancer; 2017; 8(7):1319-1323. PubMed ID: 28607608
[TBL] [Abstract][Full Text] [Related]
8. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
Abbott JJ; Oliveira AM; Nascimento AG
Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma Protuberans: A Study of 148 Patients.
Marcoval J; Moreno-Vílchez C; Torrecilla-Vall-Llosera C; Muntaner-Virgili C; Pérez Sidelnikova D; Sanjuán X; Penín RM
Dermatology; 2024; 240(3):487-493. PubMed ID: 38228098
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study.
Hoesly PM; Lowe GC; Lohse CM; Brewer JD; Lehman JS
J Am Acad Dermatol; 2015 Mar; 72(3):419-25. PubMed ID: 25582537
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
[TBL] [Abstract][Full Text] [Related]
15. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.
Minter RM; Reith JD; Hochwald SN
J Surg Oncol; 2003 Mar; 82(3):201-8. PubMed ID: 12619065
[TBL] [Abstract][Full Text] [Related]
16. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.
Stacchiotti S; Astolfi A; Gronchi A; Fontana A; Pantaleo MA; Negri T; Brenca M; Tazzari M; Urbini M; Indio V; Colombo C; Radaelli S; Brich S; Dei Tos AP; Casali PG; Castelli C; Dagrada GP; Pilotti S; Maestro R
Mol Cancer Res; 2016 Sep; 14(9):820-9. PubMed ID: 27256159
[TBL] [Abstract][Full Text] [Related]
17. [Realization of clinical diagnoses and treatment for dermatofibrosarcoma protuberans].
Cai H; Shi YQ; Wang YN; Zhu HY; Mo SJ
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):678-82. PubMed ID: 15329259
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation.
Kuzel P; Mahmood MN; Metelitsa AI; Salopek TG
J Cutan Med Surg; 2015; 19(1):28-34. PubMed ID: 25775660
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
